| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| [2] VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 2 | Bladder cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 3 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| 4 | EGFR tyrosine kinase inhibitor resistance 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 5 | Fluid shear stress and atherosclerosis 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 6 | Focal adhesion 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 7 | Gastric acid secretion 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| 8 | HIF-1 signaling pathway 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 9 | Human cytomegalovirus infection 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 10 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 11 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 12 | MAPK signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 13 | Metabolic pathways 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| 14 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 15 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| 16 | Pancreatic cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 17 | Pathways in cancer 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 18 | PI3K-Akt signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 19 | Proteoglycans in cancer 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 20 | Rap1 signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 21 | Ras signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 22 | Relaxin signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| [2] VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 23 | Renal cell carcinoma 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 24 | Rheumatoid arthritis 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 25 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |